We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News ECR 2021 Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New AI-Based Image Analysis Platform Enables Physicians to Analyze CT and MRI Scans in Half the Time of Traditional Methods

By MedImaging International staff writers
Posted on 21 Jan 2021
The US Food and Drug Administration (FDA) has granted 510(k) clearance for a new image analysis platform that enables physicians to analyze CT and MRI scans in half the time of traditional methods.

The new image analysis platform named AI Mass has been launched by AI Metrics, LLC (Birmingham, AL, USA) which has successfully implemented augmented intelligence - the concept of using artificial intelligence (AI) to improve human performance. The AI Metrics platform utilizes AI-assisted workflows to improve accuracy and consistency, and dramatically reduce errors.

Illustration
Illustration

The first application on AI Mass assists radiologists with image analysis and reporting of advanced cancer over time. During clinical trials for novel therapeutics, a patient’s response to therapy is assessed over time using detailed criteria. Such criteria require highly-controlled tumor measurements and calculations of percent changes in tumor size. In clinical practice, assessments are more subjective and lack standardization due to time constraints placed upon physicians.

“Our goal was to design a simple, intuitive platform in which radiologists could assess medical images from patients with minimal errors and a high level of accuracy, consistency, and efficiency,” said Dr. Andrew Smith, CEO and Founder of AI Metrics. “To do this, we had to break free from outdated methods and create an entirely new image viewer that supports AI and best-practice workflows that generate crystal clear data and reports. We started with advanced cancer and lymphoma, and are now broadening our platform to include early-stage cancers.”

“We solved the efficiency and standardization with a combination of AI and guided workflows that capture the best aspects of clinical trials and bring them into clinical practice,” added Smith. “This advanced technology completely changes the standard of care - for radiologists, oncologists and patients. As a practicing radiologist and researcher, I’ve envisioned for some time being able to use a system like this, and I am excited to see years of design work finally materialize into an incredible product.”

Related Links:
AI Metrics, LLC


Latest Industry News News